As the number of claims in this federal litigation tops 3,500, the Centers for Medicare & Medicaid Services (CMS) announced that Eli Lilly has agreed to enter the negotiation program for Trulicity
Arch Physiol Biochem 122(4):200213
Supplement contamination with undeclared ingredients, including prescription medications or banned substances, has been documented by FDA analyses
437 In cisplatin-sensitive oral squamous cell carcinoma, the autophagy-associated protein LC3B-II was found to be enriched in EVs, potentially modulating drug sensitivity in neighboring cells via miRNA transfer, highlighting its promise as a noninvasive biomarker for cisplatin resistance
20-50% for oral supplements) In recent years, the wellness industry has witnessed a significant shift toward personalized, on-demand care
Brain Behav 10(8):e01726